Firazyr 30 mg/3mL
icatibant acetate · INJECTION, SOLUTION · Takeda Pharmaceuticals America, Inc.
Firazyr is a injection, solution containing icatibant acetate at 30 mg/3mL, taken subcutaneous. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Firazyr
- Generic Name
- icatibant acetate
- NDC Code (Product)
54092-702- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 30 mg/3mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA022150
- Marketing Start
- 08/25/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is Firazyr used for?
Firazyr contains icatibant acetate. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Firazyr a controlled substance?
Firazyr is not classified as a controlled substance by the DEA.
What is the generic name for Firazyr?
The generic name for Firazyr is icatibant acetate. There are no other listed brand versions of icatibant acetate.
What is the NDC code for Firazyr 30 mg/3mL?
The NDC (National Drug Code) for Firazyr 30 mg/3mL is 54092-702, listed by Takeda Pharmaceuticals America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)